Medical News on Cancer
Data shows LBH589 significantly improved progression-free survival in patients with multiple myeloma
Jun 05, 2014
Novartis presented results from a pivotal Phase III trial showing a 37% improvement in progression-free survival (PFS) when using the investigational compound LBH589 (panobinostat) in combination... Read More
'Liquid biopsy' offers new way to track lung cancer
Jun 05, 2014
Scientists have shown how a lung cancer patient's blood sample could be used to monitor and predict their response to treatment paving the way for personalised medicine for the disease. Read More
Study shows Zykadia™ shrank tumors in the majority of patients with ALK+ NSCLC, regardless of prior ALK treatment
Jun 05, 2014
Novartis has announced data showing Zykadia™ (ceritinib, previously known as LDK378) shrank tumors in patients with anaplastic lymphoma kinase-positive (ALK+) non-small cell lung cancer... Read More
For the first time tumor chromosomal translocations reproduced in human cells
Jun 05, 2014
Scientists from the Spanish National Cancer Research Centre (CNIO) and the Spanish National Cardiovascular Research Centre (CNIC) have been able to reproduce, for the first time in human cells... Read More
Half a million cancers prevented by colorectal cancer screening
Jun 05, 2014
An estimated half a million cancers were prevented by colorectal cancer screening in the United States from 1976 to 2009, report researchers from the Cancer Outcomes, Public Policy, and Effectiveness... Read More
Engineered aptimer targets malignant and tumor-associated T cells
Jun 05, 2014
The transcription factor STAT3 mediates tumor survival, proliferation, invasion, and immunosuppression, and is persistently activated in tumor cells and tumor-associated immune cells. Read More
Public health often ignored in transportation policy: major roads built in poorest neighborhoods
Jun 05, 2014
A new study from the University of Colorado Denver shows public health issues are often ignored in many transportation projects, especially when major roads are built through lower-income... Read More
Researchers deliver double dose of lung cancer discoveries
Jun 04, 2014
Researchers at UCLA's Jonsson Comprehensive Cancer Center (JCCC) are reporting exciting dual discoveries in the treatment of non-small-cell lung cancer (NSCLC), which accounts for about 85 percent... Read More
New study data find Avastin® (bevacizumab) and cetuximab help patients with KRAS wild-type advanced bowel cancer live similar length of time
Jun 04, 2014
CALGB 80405, a large, independent, phase III study, designed to assess the superiority in overall survival (OS) of cetuximab over Avastin® (bevacizumab) when combined with either FOLFOX or... Read More
Nonadherence to leukemia maintenance medication in childhood triples relapse risk
Jun 04, 2014
An estimated 25 percent of children in remission from acute lymphocytic leukemia (ALL) are missing too many doses of an essential maintenance medication that minimizes their risk of relapse... Read More
Previous Page Next Page